APA (7th ed.) Citation

S, L., A, C., JD, G., T, K., SK, M., E, B., . . . B, M. (2022). [89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer. Molecular cancer therapeutics, 21(3), 440. https://doi.org/10.1158/1535-7163.MCT-21-0590

Chicago Style (17th ed.) Citation

S, Lee, et al. "[89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer." Molecular Cancer Therapeutics 21, no. 3 (2022): 440. https://doi.org/10.1158/1535-7163.MCT-21-0590.

MLA (9th ed.) Citation

S, Lee, et al. "[89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer." Molecular Cancer Therapeutics, vol. 21, no. 3, 2022, p. 440, https://doi.org/10.1158/1535-7163.MCT-21-0590.